Xultophy

Drug Novo Nordisk Inc
Total Payments
$79,670
Transactions
340
Doctors
340
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2017 $79,670 340 340

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $79,670 340 100.0%

Top Doctors Receiving Payments for Xultophy — Page 14

Doctor Specialty Location Total Records
, M.D Family Medicine Woodland, CA $170.00 1
Sanjiv Gupta Ashland, KY $170.00 1
, M.D Endocrinology, Diabetes & Metabolism North Providence, RI $170.00 1
, MD Endocrinology, Diabetes & Metabolism Mobile, AL $170.00 1
, MD Internal Medicine Georgetown, DE $170.00 1
, MD Pulmonary Disease Charlotte, NC $170.00 1
, M.D Internal Medicine Peru, IL $170.00 1
, MD Family Medicine El Centro, CA $170.00 1
, MD Internal Medicine Pittsburgh, PA $170.00 1
, MD Internal Medicine Mobile, AL $170.00 1
, M.D Internal Medicine Staten Island, NY $170.00 1
, MD Internal Medicine Garner, NC $170.00 1
, DO Emergency Medicine Plattsburgh, NY $170.00 1
, MD Internal Medicine Mason City, IA $170.00 1
, M.D Family Medicine Glendale, AZ $170.00 1

About Xultophy

Xultophy is a drug associated with $79,670 in payments to 340 healthcare providers, recorded across 340 transactions in the CMS Open Payments database. The primary manufacturer is Novo Nordisk Inc.

Payment data is available from 2017 to 2017. In 2017, $79,670 was paid across 340 transactions to 340 doctors.

The most common payment nature for Xultophy is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($79,670, 100.0% of total).